150 related articles for article (PubMed ID: 6854193)
1. Effect of tamoxifen on growth and prolactin secretion of rat pituitary tumours.
Prysor-Jones RA; Silverlight JJ; Jenkins JS
J Endocrinol; 1983 May; 97(2):261-6. PubMed ID: 6854193
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen suppresses both the growth of prolactin-secreting pituitary tumours and normal prolactin synthesis in the rat.
de Quijada M; Timmermans HA; Lamberts SW
J Endocrinol; 1980 Jul; 86(1):109-16. PubMed ID: 7430882
[TBL] [Abstract][Full Text] [Related]
3. Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1981 Mar; 88(3):463-9. PubMed ID: 7217831
[TBL] [Abstract][Full Text] [Related]
4. Effect of bromocriptine, ergotamine and other ergot alkaloids on the hormone secretion and growth of a rat pituitary tumour.
Prysor-Jones RA; Jenkins JS
J Endocrinol; 1980 Jul; 86(1):147-53. PubMed ID: 7430884
[TBL] [Abstract][Full Text] [Related]
5. Effect of antiestrogens on pituitary prolactin production in normal and pituitary tumor-bearing rats.
Nagy I; Valdenegro CA; MacLeod RM
Neuroendocrinology; 1980 Jun; 30(6):389-95. PubMed ID: 7383277
[TBL] [Abstract][Full Text] [Related]
6. DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine.
Lloyd HM; Jacobi JM; Willgoss DA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):79-85. PubMed ID: 7641414
[TBL] [Abstract][Full Text] [Related]
7. Effect of tamoxifen administration on prolactin release by invasive prolactin-secreting pituitary adenomas.
Lamberts SW; Verleun T; Oosterom R
Neuroendocrinology; 1982; 34(5):339-42. PubMed ID: 7078703
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine.
Kalbermann LE; Machiavelli GA; De Nicola AF; Weissenberg LS; Burdman JA
J Endocrinol; 1980 Nov; 87(2):221-4. PubMed ID: 7430920
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy after combined treatment with bromocriptine and tamoxifen in two patients with pituitary prolactinomas.
Koizumi K; Aono T
Fertil Steril; 1986 Aug; 46(2):312-4. PubMed ID: 3089843
[TBL] [Abstract][Full Text] [Related]
10. Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.
Prysor-Jones RA; Kennedy SJ; O'Sullivan JP; Jenkins JS
Acta Endocrinol (Copenh); 1981 Sep; 98(1):14-23. PubMed ID: 6116372
[TBL] [Abstract][Full Text] [Related]
11. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.
Cronin MJ; Perkins SN; Keefer DA; MacLeod RM
Mol Cell Endocrinol; 1982 Oct; 28(2):229-46. PubMed ID: 7128925
[TBL] [Abstract][Full Text] [Related]
12. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
Lamberts SW; de Quijada M; Klijn JG
J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
[TBL] [Abstract][Full Text] [Related]
13. [Bromocriptine and tamoxifen--a new therapeutic approach in suppression-resistant prolactin-secreting adenomas].
Völker W; Gehring WG; von zur Mühlen A; Schneider J
Geburtshilfe Frauenheilkd; 1982 Nov; 42(11):790-7. PubMed ID: 6924910
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
[TBL] [Abstract][Full Text] [Related]
15. Prolactin secretion and dopamine receptors of the MtTW15 transplantable pituitary tumour.
Cronin MJ; Keefer DA; Valdenegro CA; Dabney LG; MacLeod RM
J Endocrinol; 1982 Sep; 94(3):347-58. PubMed ID: 7119646
[No Abstract] [Full Text] [Related]
16. Influence of bromocriptine and oestrogen on prolactin synthesis, secretion and tumour growth in vivo in rats.
Vrontakis ME; Thliveris JA; Friesen HG
J Endocrinol; 1987 Jun; 113(3):383-8. PubMed ID: 3625096
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
[TBL] [Abstract][Full Text] [Related]
18. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study.
Bergström M; Muhr C; Lundberg PO; Bergström K; Gee AD; Fasth KJ; Långström B
J Comput Assist Tomogr; 1987; 11(5):815-9. PubMed ID: 3498743
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of extracellular matrix on secretion of prolactin and growth hormone by rat pituitary tumour cells in vitro.
Prysor-Jones RA; Silverlight JJ; Jenkins JS
Acta Endocrinol (Copenh); 1985 Feb; 108(2):156-60. PubMed ID: 3918400
[TBL] [Abstract][Full Text] [Related]
20. Pure alpha-subunit-secreting mouse pituitary tumor: inhibition of growth and secretion by combined treatment with thyroxine and bromocriptine.
Kieffer JD; Ross DS; Shupnik MA; Ridgway EC
Endocrinology; 1985 Oct; 117(4):1418-23. PubMed ID: 2411527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
